Public Health :: New Bench Book helps judges make speedy decisions about pressing public health cases

What if there was an outbreak of avian flu in Pennsylvania and public health officials had to institute quarantines to stop the spread of the deadly disease? How would the state?s courts respond if someone resisted or challenged a quarantine in court, particularly since no Pennsylvania case law, statute or court ruling has ever established specifically who can petition a court to institute a quarantine or what procedures to follow to do so?

Bird Flu :: Egyptian boy tests positive for bird flu

A four-year-old boy from the Nile Delta town of Daqahliya tested positive for the H5N1 virus on 11 March. Sayyid al-Abbasi, a spokesman for the Ministry of Health, said the boy had contracted the virus from domestic birds raised by his family. He added that his condition was stable.

Influenza :: Roche files supplemental new drug application for Tamiflu

Roche has filed a supplemental new drug application (sNDA) with the U.S. Food and Drug Administration (FDA) to market Tamiflu (oseltamivir phosphate) capsules in pediatric doses of 30 mg and 45 mg. Tamiflu, which is indicated for the prevention and treatment of influenza types A and B in patients one year and older, is currently available in a 75 mg capsule for adults as well as liquid suspension formulation for children.

Avian Flu :: UCI scientists reconstruct migration of avian flu virus

UC Irvine researchers have combined genetic and geographic data of the H5N1 avian flu virus to reconstruct its history over the past decade. They found that multiple strains of the virus originated in the Chinese province of Guangdong, and they identified many of the migration routes through which the strains spread regionally and internationally.

Influenza :: GSK’s pre-pandemic influenza vaccine protects against H5N1

GlaxoSmithKline (GSK) announces clinical trial data from two new studies, which show, for the first time, that GSK?s candidate pre-pandemic split antigen H5N1 vaccine, formulated with GSK?s proprietary adjuvant system, provides a substantial level of cross-immunity against a ?drifted? (diverse) strain of H5N1.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack